These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 14035396)

  • 1. [Experiences and results in the chemotherapy of malignant gynecological tumors].
    KRAHE M
    Med Welt; 1963 Jun; 25():1333-8. PubMed ID: 14035396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy of malignant tumors in gynecology].
    KIRCHHOFF H
    Tokoginecol Pract; 1963 May; 22():147-8. PubMed ID: 14032970
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiblastic chemotherapy in gynecological oncology].
    Macchioni B; Poggio A; Tanferna M
    Minerva Ginecol; 1968 Dec; 20(24):1985-93. PubMed ID: 5736215
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON THE SUBJECT OF THE MEDICAL THERAPY OF GYNECOLOGICAL TUMORS].
    CARAZZONE PF
    Minerva Med; 1963 Jul; 54():2190-1. PubMed ID: 14055079
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reasonable applications of chemotherapy in gynecological malignancy].
    Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):73-4. PubMed ID: 16640850
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapeutic tactics in malignant tumors of the female genitalia].
    Dvorák O
    Cesk Gynekol; 1970 May; 35(4):203-5. PubMed ID: 5420252
    [No Abstract]   [Full Text] [Related]  

  • 7. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
    Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of cytostatics in gynecological tumor therapy].
    KEPP R; KOESTER H
    Med Monatsschr; 1962 Sep; 16():588-92. PubMed ID: 14032014
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems of chemotherapy of malignant female genital tumors].
    SEREBROV AI
    Akush Ginekol (Mosk); 1959; 35(3):3-7. PubMed ID: 13660995
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential underdosing of carboplatin in gynecological malignancies.
    de Lemos ML; Hamata L; Conklin J; Swenerton K
    Gynecol Oncol; 2006 Sep; 102(3):599. PubMed ID: 16815537
    [No Abstract]   [Full Text] [Related]  

  • 11. [The possibilities of retaining fertility in malignant gynecological tumors].
    Lampé L
    Magy Onkol; 2005; 49(4):331-5. PubMed ID: 16518478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Classification of malignant gynecological tumors in relation to standardization of statistics].
    Wolff JP
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(5):Suppl:386-8. PubMed ID: 5759252
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
    An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell-based treatments for gynecological solid tumors.
    Perillo A; Ferrandina G; Pierelli L; Bonanno G; Scambia G; Mancuso S
    Eur Rev Med Pharmacol Sci; 2005; 9(2):93-102. PubMed ID: 15945498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental studies on selective chemotherapy of gynecologic neoplasms].
    KRAHE M; LIMBURG H; PIES U
    Zentralbl Gynakol; 1962 Mar; 84():391-402. PubMed ID: 14035394
    [No Abstract]   [Full Text] [Related]  

  • 16. Luteinizing hormone-releasing hormone receptor-targeted chemotherapy using AN-152.
    Emons G; Sindermann H; Engel J; Schally AV; Gründker C
    Neuroendocrinology; 2009; 90(1):15-8. PubMed ID: 19521066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which gynecological and obstetric patients want to attend psychosomatic services?
    Weidner K; Siedentopf F; Zimmermann K; Bittner A; Richter J; Joraschky P; Distler W; Stobel-Richter Y
    J Psychosom Obstet Gynaecol; 2008 Dec; 29(4):280-9. PubMed ID: 19065397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone marrow transfusion in the antiblastic therapy of tumors of the female genitalia].
    CUTRERA A
    Riv Ostet Ginecol; 1962 Oct; 17():743-8. PubMed ID: 14024400
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of tolerance against human chorionic gonadotropin at malignant and benign tumors of female reproduction system.
    Akhvlediani L; Nagervadze M; Dumbadze G
    Georgian Med News; 2009 Jun; (171):20-4. PubMed ID: 19578206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach?
    Memtsas V; Zarros A; Theocharis S
    Expert Opin Ther Targets; 2009 Sep; 13(9):1105-20. PubMed ID: 19604124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.